Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 22317901000001115 | Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 91084301000001116 | Lidocaine 400mg/20ml (2%) / Adrenaline (base) 100micrograms/20ml (1 in 200,000) solution for injection vials 5 vial | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Is pack of | Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials | false | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has active ingredient | Lidocaine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has active ingredient | Epinephrine bitartrate | false | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has VMP | Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Epinephrine | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has specific active ingredient | Epinephrine bitartrate | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has specific active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Has basis of strength substance | Epinephrine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) 5 vial 5 x 20ml vials | Is a | True | Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials 5 vial | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR